CD4 and cutaneous mastocytosis: In addition, we estimated and compared the prevalence of CrAg positivity, the incidence of CM and all-cause mortality between persons with CD4+ T cell counts< 100 and persons with CD4+ T cell counts between 100 and 200 cells/μL.